Skip to main content

CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72107

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-72107

Key Product Details

Species Reactivity

Human

Applications

Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # OTI1F1

Format

Azide and BSA Free

Concentration

LYOPH mg/ml

Product Specifications

Immunogen

Full length human recombinant protein of human SLAMF7 (NP_067004) produced in HEK293T cell.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Theoretical MW

37.2 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Scientific Data Images for CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free

Western Blot: CRACC/SLAMF7 Antibody (OTI1F1)Azide and BSA Free [NBP2-72107]

Western Blot: CRACC/SLAMF7 Antibody (OTI1F1)Azide and BSA Free [NBP2-72107]

Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7 (RC220985, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SLAMF7. Positive lysates (100ug) and (20ug).
Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107]

Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107]

Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107] - Staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-SLAMF7 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120 degrees C for 3min.
Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107]

Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107]

Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free [NBP2-72107] - Staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-SLAMF7 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120 degrees C for 3min.

Applications for CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free

Application
Recommended Usage

Immunohistochemistry

1:150

Western Blot

1:2000

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Reconstitution

we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process.

Formulation

Lyophilized from PBS (pH 7.3) with 8% Trehalose

Format

Azide and BSA Free

Preservative

No Preservative

Concentration

LYOPH mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: CRACC/SLAMF7

Isoform 1 mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway. May play a role in lymphocyte adhesion.

Alternate Names

CD319, SLAMF7

Gene Symbol

SLAMF7

Additional CRACC/SLAMF7 Products

Product Documents for CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CRACC/SLAMF7 Antibody (OTI1F1) - Azide and BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...